| Item Type | Name |
|
Concept
|
A549 Cells
|
|
Concept
|
Carcinoma, Non-Small-Cell Lung
|
|
Concept
|
Cell Adhesion
|
|
Concept
|
Cell Communication
|
|
Concept
|
Cell Cycle
|
|
Concept
|
Cell Differentiation
|
|
Concept
|
Cell Division
|
|
Concept
|
Cell Line
|
|
Concept
|
Cell Movement
|
|
Concept
|
HeLa Cells
|
|
Concept
|
Neoplastic Cells, Circulating
|
|
Concept
|
Cell Death
|
|
Concept
|
Cell Cycle Proteins
|
|
Concept
|
Endothelial Cells
|
|
Concept
|
Tumor Cells, Cultured
|
|
Concept
|
Cell Cycle Checkpoints
|
|
Concept
|
G2 Phase Cell Cycle Checkpoints
|
|
Concept
|
G1 Phase Cell Cycle Checkpoints
|
|
Concept
|
Resting Phase, Cell Cycle
|
|
Concept
|
Cell Proliferation
|
|
Concept
|
Platelet Endothelial Cell Adhesion Molecule-1
|
|
Concept
|
Active Transport, Cell Nucleus
|
|
Concept
|
Muscle Cells
|
|
Concept
|
Cell Line, Tumor
|
|
Concept
|
Cell Separation
|
|
Concept
|
Cell Survival
|
|
Academic Article
|
Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
|
|
Academic Article
|
Exploitation of Exosomes as Nanocarriers for Gene-, Chemo-, and Immune-Therapy of Cancer.
|
|
Academic Article
|
Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration.
|
|
Academic Article
|
Cancer stem cells: progress and challenges in lung cancer.
|
|
Academic Article
|
HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy.
|
|
Academic Article
|
Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells.
|
|
Academic Article
|
Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
|
|
Academic Article
|
Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage.
|
|
Academic Article
|
Tumor-targeted Nanoparticle Delivery of HuR siRNA Inhibits Lung Tumor Growth In Vitro and In Vivo By Disrupting the Oncogenic Activity of the RNA-binding Protein HuR.
|
|
Academic Article
|
HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells.
|
|
Academic Article
|
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
|
|
Academic Article
|
Chemo-biologic combinatorial drug delivery using folate receptor-targeted dendrimer nanoparticles for lung cancer treatment.
|
|
Academic Article
|
Molecular Targeting of HuR Oncoprotein Suppresses MITF and Induces Apoptosis in Melanoma Cells.
|
|
Academic Article
|
Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy.
|
|
Academic Article
|
Combinatorial Nanoparticle Delivery of siRNA and Antineoplastics for Lung Cancer Treatment.
|
|
Academic Article
|
Tumor-Targeted Dendrimer Nanoparticles for Combinatorial Delivery of siRNA and Chemotherapy for Cancer Treatment.
|
|
Academic Article
|
Increased uptake of liposomal-DNA complexes by lung metastases following intravenous administration.
|
|
Academic Article
|
Adenovirus-mediated PTEN treatment combined with caffeine produces a synergistic therapeutic effect in colorectal cancer cells.
|
|
Academic Article
|
Adenovirus-mediated mda-7 (IL24) gene therapy suppresses angiogenesis and sensitizes NSCLC xenograft tumors to radiation.
|
|
Academic Article
|
Local and systemic inhibition of lung tumor growth after nanoparticle-mediated mda-7/IL-24 gene delivery.
|
|
Academic Article
|
Targeted drug and gene delivery systems for lung cancer therapy.
|
|
Academic Article
|
IL-24 inhibits lung cancer cell migration and invasion by disrupting the SDF-1/CXCR4 signaling axis.
|
|
Academic Article
|
Phosphorylation of interleukin (IL)-24 is required for mediating its anti-cancer activity.
|
|
Academic Article
|
IL-24 modulates the high mobility group (HMG) A1/miR222 /AKT signaling in lung cancer cells.
|
|
Academic Article
|
Inhibition of human lung cancer growth following adenovirus-mediated mda-7 gene expression in vivo.
|
|
Academic Article
|
Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer.
|
|
Academic Article
|
mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft.
|
|
Academic Article
|
Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
|
|
Academic Article
|
Determinant role for the gep oncogenes, Ga12/13, in ovarian cancer cell proliferation and xenograft tumor growth.
|
|
Academic Article
|
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo.
|
|
Academic Article
|
MDA-7 negatively regulates the beta-catenin and PI3K signaling pathways in breast and lung tumor cells.
|
|
Academic Article
|
Melanoma differentiation-associated gene 7/interleukin (IL)-24 is a novel ligand that regulates angiogenesis via the IL-22 receptor.
|
|
Academic Article
|
The tumor suppressor activity of MDA-7/IL-24 is mediated by intracellular protein expression in NSCLC cells.
|
|
Academic Article
|
Liposomal vector mediated delivery of the 3p FUS1 gene demonstrates potent antitumor activity against human lung cancer in vivo.
|
|
Academic Article
|
Activation of the Fas-FasL signaling pathway by MDA-7/IL-24 kills human ovarian cancer cells.
|
|
Academic Article
|
mda-7/IL24 kills pancreatic cancer cells by inhibition of the Wnt/PI3K signaling pathways: identification of IL-20 receptor-mediated bystander activity against pancreatic cancer.
|
|
Academic Article
|
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.
|
|
Academic Article
|
MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo.
|
|
Academic Article
|
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
|
|
Academic Article
|
Cancer targeting using tumor suppressor genes.
|
|
Academic Article
|
Adenovirus-mediated interleukin (IL)-24 immunotherapy for cancer.
|
|
Academic Article
|
EGFR-targeted hybrid plasmonic magnetic nanoparticles synergistically induce autophagy and apoptosis in non-small cell lung cancer cells.
|
|
Academic Article
|
EGFR-targeted plasmonic magnetic nanoparticles suppress lung tumor growth by abrogating G2/M cell-cycle arrest and inducing DNA damage.
|
|
Academic Article
|
Exosomes: a role for naturally occurring nanovesicles in cancer growth, diagnosis and treatment.
|
|
Academic Article
|
HuR-targeted nanotherapy in combination with AMD3100 suppresses CXCR4 expression, cell growth, migration and invasion in lung cancer.
|
|
Academic Article
|
PI3 kinase blockade by Ad-PTEN inhibits invasion and induces apoptosis in RGP and metastatic melanoma cells.
|
|
Academic Article
|
The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cells.
|
|
Academic Article
|
mda-7/IL-24, a novel cancer selective apoptosis inducing cytokine gene: from the laboratory into the clinic.
|
|
Academic Article
|
Ectopic production of MDA-7/IL-24 inhibits invasion and migration of human lung cancer cells.
|
|
Academic Article
|
Nanoparticle based systemic gene therapy for lung cancer: molecular mechanisms and strategies to suppress nanoparticle-mediated inflammatory response.
|
|
Academic Article
|
Bystander activity of Ad-mda7: human MDA-7 protein kills melanoma cells via an IL-20 receptor-dependent but STAT3-independent mechanism.
|
|
Academic Article
|
Selective induction of cell cycle arrest and apoptosis in human prostate cancer cells through adenoviral transfer of the melanoma differentiation-associated -7 (mda-7)/interleukin-24 (IL-24) gene.
|
|
Academic Article
|
Inhibition of Src kinase activity by Ad-mda7 suppresses vascular endothelial growth factor expression in prostate carcinoma cells.
|
|
Academic Article
|
Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
|
|
Academic Article
|
Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways.
|
|
Academic Article
|
Nanoparticle-mediated gene delivery to the lung.
|
|
Academic Article
|
Targeting single-walled carbon nanotubes for the treatment of breast cancer using photothermal therapy.
|
|
Academic Article
|
YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways.
|
|
Grant
|
HuR Targeted Nanotherapy for Lung Cancer
|
|
Grant
|
Evaluate the antiangiogenic properties of mda-7/IL-24
|
|
Grant
|
Systemic Non-Viral Gene Therapy for Cancer
|
|
Grant
|
Preclinical Development and Testing of Multifunctional Tumor-Targeted Hybrid Nano
|
|
Grant
|
Molecular Impact of Platinum Drugs on the Proteasome and SQSTM1_P62 Complexes_A Paradigm Shift in Resistance
|
|
Grant
|
ShEEP Request for CytoViva 3D Darkfield Hyperspectral Microscope
|
|
Academic Article
|
Interleukin (IL)-24: Reconfiguring the Tumor Microenvironment for Eliciting Antitumor Response.
|
|
Academic Article
|
Extracellular Vesicles in Oncology: from Immune Suppression to Immunotherapy.
|
|
Academic Article
|
ZIP4 promotes non-small cell lung cancer metastasis by activating snail-N-cadherin signaling axis.
|
|
Academic Article
|
Investigating Cancerous Exosomes' Effects on CD8+ T-Cell IL-2 Production in a 3D Unidirectional Flow Bioreactor Using 3D Printed, RGD-Functionalized PLLA Scaffolds.
|